Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...

Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...

Dragonfly Energy Holdings Corp. engages in the manufacturing and sale of deep cycle lithium-ion batteries for recreational vehicles, marine vessels, solar and off-grid residence industries, and ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Hodson will switch from Anderson Motorsport to drive one of two Triple Eight-built Holden ZB Commodores to be run by MSR. The team is set to test at Queensland Raceway on Monday with Trans Am drivers ...

MST-VTT is a large-scale video benchmark for video understanding. It contains 200K clip-sentence pairs. MSR-VTT provides 10K web video clips where every video has 20 human-written annotations in ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

Built on Microsoft Research Asia’s more than two-decade advanced research and technology transfer foundation, Industry Innovation Center is staffed with a group of world-class researchers and applied ...

Microsoft is reinforcing its commitment to advancing AI research and innovation across the Asia-Pacific region with the opening of Microsoft Research Asia – Tokyo. The Tokyo lab will focus on critical ...